Holen Sie sich die Stockscreener-App
4.52
0.44%
-0.02
Vorhandelsmarkt:
4.46
-0.06
-1.33%
Niagen Bioscience Inc Aktie (NAGE) Neueste Nachrichten
Street Watch: Is Niagen Bioscience Inc stock risky to hold nowMarket Activity Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Whale Trades: How do insiders feel about Niagen Bioscience Inc2026 Macro Moves & Breakout Confirmation Alerts - baoquankhu1.vn
Niagen Bioscience doubles share buyback program to $20 million By Investing.com - Investing.com Canada
Niagen Bioscience Increases Share Repurchase Program to $20 Million - PharmiWeb.com
Niagen Bioscience Doubles Share Repurchase Authorization to $20M - TipRanks
Niagen Bioscience doubles share buyback program to $20 million - Investing.com
Niagen Bioscience raises share buyback authorization to $20M, $2.6M repurchased to date - TradingView
Niagen Bioscience (NAGE) boosts share repurchase authorization to $20 million - Stock Titan
Will Niagen Bioscience Inc outperform its industry peers2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Niagen Bioscience, Inc. announces an Increase in Equity Buyback. - marketscreener.com
Niagen Bioscience to Present at the 38th Annual ROTH Conference - PharmiWeb.com
Niagen Bioscience research program reaches 300 material agreements By Investing.com - Investing.com South Africa
Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Nia - PharmiWeb.com
Niagen Bioscience research program reaches 300 material agreements - Investing.com
National Advertising Division Recommends Niagen Update Tru Niagen NAD+ Claims - Happi | Household And Personal Products Industry
Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen - Business Wire
Niagen Bioscience reaches 300 research agreements milestone By Investing.com - Investing.com Australia
Latest NAGE NewsNiagen Bioscience Announces Pharmaceutical-... - Stock Titan
Decliners Report: What is the Moat Score of Niagen Bioscience Inc2026 Retail Activity & Safe Entry Momentum Tips - baoquankhu1.vn
National Advertising Division Recommends Niagen Modify or Discontinue Certain Tru Niagen NAD+ Claims; Niagen to Appeal - The Manila Times
Bank Watch: How correlated is Niagen Bioscience Inc to the S P5002026 Intraday Action & Low Drawdown Trading Strategies - baoquankhu1.vn
Analyst Calls: Can Niagen Bioscience Inc stock outperform in a bear marketRisk Management & Weekly Hot Stock Watchlists - baoquankhu1.vn
Chart Watch: Is Niagen Bioscience Inc stock risky to hold nowMarket Volume Report & Technical Pattern Recognition Alerts - baoquankhu1.vn
Niagen Bioscience (NAGE) Earnings Transcript - AOL.com
Niagen Bioscience targets 10–15% revenue growth for 2026 while expanding injectable product line - MSN
Niagen Bioscience Launches Niagen Skincare Innovation Lab - Happi | Household And Personal Products Industry
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and D - GuruFocus
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® - 巴士的報
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen - itemonline.com
Earnings call transcript: Niagen Bioscience’s Q4 2025 revenue grows 16% - Investing.com Nigeria
Risk Off: Is now the right time to enter Niagen Bioscience Inc2026 Momentum & Risk Managed Investment Signals - baoquankhu1.vn
Is Niagen Bioscience Inc. (OCD1) stock undervalued historically2026 Top Gainers & Safe Entry Trade Reports - Naître et grandir
Sentiment Review: Can Niagen Bioscience Inc be recession proofTrade Entry Report & Safe Entry Trade Reports - baoquankhu1.vn
Why Niagen Bioscience Inc. stock appeals to dividend seekersForecast Cut & Low Risk High Reward Ideas - Naître et grandir
Niagen Bioscience (NASDAQ:NAGE) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Value Recap: Will Niagen Bioscience Inc stock hit new highs in YEAR - baoquankhu1.vn
Niagen Bioscience (NAGE) Margin Rise To 13.4% Tests Bullish Narrative Targets - simplywall.st
Analysts Are Bullish on These Healthcare Stocks: Niagen Bioscience (NAGE), Daxor (DXR) - The Globe and Mail
Niagen Bioscience rallies 18% after hours: Here's why - MSN
Niagen Bioscience FY25 Net Sales Jump 30%; Sees 10-15% Growth In FY26 - Nasdaq
Canaccord Genuity Group Cuts Niagen Bioscience (NASDAQ:NAGE) Price Target to $13.00 - MarketBeat
Niagen Bioscience 2025 Financials: $129.4M Revenue, $17.4M ProfitNews and Statistics - IndexBox
Niagen Bioscience (NAGE) Valuation Check After Strong 2025 Results And Moderated 2026 Growth Outlook - simplywall.st
Niagen Bioscience Rallies 18% After Hours: Here's Why - Benzinga
Niagen Bioscience Doubles Annual Profit, CEO Signals Acquisition Hunt And GLP-1-Style Expansion— Stock Jumps After-Hours (UPDATED) - Benzinga
NAGE Earnings History & Surprises | EPS & Revenue Results | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
Niagen Bioscience Inc (NAGE) Q4 2025 Earnings Call Highlights: S - GuruFocus
Niagen Bioscience earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Niagen Bioscience (NAGE) Reports Strong Q4 and Ambitious 2026 Pl - GuruFocus
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income I - PharmiWeb.com
Niagen Bioscience (NAGE) Surges 39% Following Q4 Results and Pos - GuruFocus
Niagen Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Niagen Bioscience (NAGE) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
Earnings call transcript: Niagen Bioscience’s Q4 2025 revenue grows 16% By Investing.com - Investing.com India
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):